26 / 48
26
WFSBP 2017
Preliminary Scientific Programme /
Symposia
S-34-002
Cortical gene expression changes underlying estrogen's
effect in schizophrenia
Andrea Gogos, Australia
S-34-003
17b-estradiol effects on psychosis-like attentional
abnormalities in rats
Ina Weiner, Israel
S-34-004
Sex differences in depression: The role of neuroestrogens
Christina Dalla, Greece
T27: OBSESSIVE-COMPULSIVE DISORDERS: BASIC/
CLINICAL
S-35
08:30–10:00
New insights into the neurobiology and treatment
aspects of obsessive compulsive disorder comorbid
with schizophrenia and bipolar affective disorder
Chair:
E. Mohandas, India
Co-Chair: Narayan R. Mutalik, India
S-35-001
Neurobiology of obsessive compulsive disorder comor-
bid with schizophrenia
Narayan R. Mutalik, India
S-35-002
Evidence based management of obsessive compulsive
disorder comorbid with schizophrenia
Firoz Kazhungil, India
S-35-003
Neurobiology of obsessive compulsive disorder comor-
bid with bipolar disorder
Rajan Nishanth Jayarajan, Australia
S-35-004
Recent updates in the management of obsessive com-
pulsive disorder comorbid with Bipolar Disorder (BP)
Pawan Sharma, Nepal
T9: COGNITIVE NEUROSCIENCE
S-36 SYMPOSIUM
11:15–12:45
The role of the nucleus accumbens in psychiatry
Chair:
Jens Kuhn, Germany
Co-Chair: Leonhard Schilbach, Germany
S-36-001
The anatomy of the nucleus accumbens
Ioannis Mavridis, Greece
S-36-002
The role of nucleus accumbens in social cognition
Leonhard Schilbach, Germany
S-36-003
The role of nucleus accumbens in impulsivity
Valerie Voon, United Kingdom
S-36-004
Deep brain stimulation of the nucleus accumbens
Sina Kohl, Germany
T11: DEPRESSION: BASIC/CLINICAL
S-37
11:15–12:45
Neurobiologic imaging studies of mood disorders,
neurogenetics and antidepressant action with positron
emission tomography
Chair:
J. John Mann, USA
Co-Chair: Gitte Moos Knudsen, Denmark
S-37-001
Familial transmission of 5-HT1A autoreceptor up-reg-
ulation: An impaired serotonnergic endophenotype in
mood disorders
J. John Mann, USA
S-37-002
Molecular neuroimaging and genetics
Gitte Moos Knudsen, Denmark
S-37-003
cAMP Cascade in major depressive disorder: Downreg-
ulation in unmedicated patients and normalization with
treatment
Robert Innis, USA
S-37-004
Predictiveness of peripheral and clinical markers for PET
measurement of inflammation and monoamine oxidase:
Implications for biomarker development
Jeffrey Meyer, Canada
T43: SCHIZOPHRENIA: BASIC/CLINICAL
S-38
11:15–12:45
Treatment resistant schizophrenia: Definitions,
psychobiology and clinical treatment
Chair:
John Kane, USA
Co-Chair: Ofer Agid, Canada
S-38-001
Methodological issues in clinical trial designs for TRS
John Kane, USA
TUE